Light-Based blood treatment tested for Tough-to-Treat blood cancer
NCT ID NCT07075328
Summary
This study is testing a new treatment called OJP-001 for adults whose T-cell leukemia or lymphoma has come back after previous therapy. The treatment involves taking a drug that makes cancer cells sensitive to light, then filtering the patient's blood outside the body and exposing it to a special light to kill the cancer cells. Researchers want to find the safest dose and see if this approach can help control the disease in patients who have few other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Imamura general hospital
RECRUITINGKagoshima, Kagoshima-ken, Japan
Contact
-
Nagasaki University Hospital
RECRUITINGNagasaki, Japan
Contact
-
National Kyushu Cancer Center
RECRUITINGFukuoka, Japan
Contact
-
Sapporo Hokuyu Hospital
RECRUITINGSapporo, Hokkaido, Japan
Contact
Conditions
Explore the condition pages connected to this study.